CNR2 and Psoriasiform dermatitis: In contrast, CB2 deficiency exacerbates imiquimod-induced psoriasiform dermatitis, characterized by elevated TNF-α, IL-1β, and IL-17 expression, which is reversed by CB2 activation [83].